MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹139 Cr | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MARKSANS PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹139 Cr |
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹176 Cr |
| Mar2022 | ₹94 Cr |
How is Net Cash Inflow / Outflow of MARKSANS PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹139 Cr | 50.18 | |
| Mar2025 | ₹93 Cr | 343.90 | |
| Mar2024 | ₹21 Cr | -88.16 | |
| Mar2023 | ₹176 Cr | 86.52 | |
| Mar2022 | ₹94 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,840.0 Cr | 8% | 25.8% | 74.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 8% |
25.8% |
74.7% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses